- Myocardial infarction subtypes in patients with type 2 diabetes mellitus and the effect of liraglutide therapy (from the LEADER trial)
- Phase II trial of ifosfamide in combination with the VEGFR inhibitor sorafenib in advanced soft tissue sarcoma: A Spanish group for research on sarcomas (GEIS) study
- Anti-platelet therapy does not influence the outcome of patients undergoing hepatic resection for colorectal liver metastases, an observational study
- Breakthrough <em>Clostridium difficile</em> infection in cirrhotic patients receiving rifaximin
- Use of a 4-week up-titration regimen of roflumilast in patients with severe COPD
- Statin use and mortality in gout: A general population-based cohort study
- Retreatment with sofosbuvir plus grazoprevir/elbasvir plus ribavirin of patients with hepatitis C virus genotype 1 or 4 who previously failed an NS5A- or NS3-containing regimen: The ANRS HC34 REVENGE Study
- The association between anticholinergic drug use and rehabilitation outcome in post-acute hip fractured patients: A retrospective cohort study
- Fimasartan increases glucose-stimulated insulin secretion in patients with type 2 diabetes and hypertension compared with amlodipine
- Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: Primary results from the randomised, double-blind, phase III FUTURE 5 study
- Association of progressive multifocal leukoencephalopathy lesion volume with JC virus polymerase chain reaction results in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis
- Pooled analyses of phase III studies of ADS-5102 (amantadine) extended-release capsules for dyskinesia in Parkinson’s disease
- Continuous subcutaneous insulin infusion vs multiple daily injections in pregnant women with type 1 diabetes mellitus – A systematic review and meta-analysis of randomised controlled trials and observational studies
- Pre-surgical chemotherapy for breast cancer may be associated with improved outcomes
- Palmitoylethanolamide as adjunctive therapy in major depressive disorder: A double-blind, randomized and placebo-controlled trial
Feed Sources
